Hostname: page-component-cd9895bd7-q99xh Total loading time: 0 Render date: 2024-12-27T08:20:22.324Z Has data issue: false hasContentIssue false
  • English
  • Français

Ecstasy use and neuropathology

Published online by Cambridge University Press:  03 January 2018

J. F. Morgan
J. F. Morgan*
Affiliation:
Department of General Psychiatry, St George's Hospital Medical School, London SW17 0RE
Rights & Permissions [Opens in a new window]

Abstract

An abstract is not available for this content so a preview has been provided. As you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Columns
Information
The British Journal of Psychiatry , Volume 175 , Issue 6 , December 1999 , pp. 589
Copyright
Copyright © 1999 The Royal College of Psychiatrists 

References

McCann, U. D., Szabo, Z., Scheffel, U., et al (1998) Positron emission tomographic evidence of toxic effect of MDMA (“Ecstasy”) on brain serotonin neurons in human beings. Lancet, 352, 1433–1437.CrossRefGoogle ScholarPubMed
Morgan, J. F. (1999) Positron emission tomographic evidence of toxic effects of MDMA (‘ecstasy’) on brain serotonergic neurones in human beings: users may self medicate for axis I and II disorders. Lancet, 353, 1268–1269.CrossRefGoogle Scholar
Obrocki, J., Buchert, R., Väteriein, O., et al (1999) Ecstasy – long-term effects on the human central nervous system revealed by positron emission tomography. British Journal of Psychiatry, 175, 186–188.CrossRefGoogle ScholarPubMed
Submit a response

eLetters

No eLetters have been published for this article.